查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1802952

益生菌生物膜保护剂市场预测（至 2032 年）：按产品类型、应用、最终用户和地区进行的全球分析

Probiotic Biofilm Protectors Market Forecasts to 2032 - Global Analysis By Product Type (Probiotic Strains, Postbiotics & Synbiotics and Delivery Formats), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球益生菌生物膜保护剂市场预计在 2025 年价值 17.3 亿美元，到 2032 年将达到 47.6 亿美元，预测期内的复合年增长率为 15.5%。

益生菌生物膜保护剂是生长在皮肤、口腔和胃等黏膜表面的有益细菌，它们会形成一层称为生物膜的保护层。这种生物膜可作为生物和物理屏障，防止危险病原体附着、定植并引起感染疾病。与通常与疾病相关的致病性生物膜不同，益生菌生物膜透过增强免疫力、产生抗菌化合物和稳定微生物群来增强人体的防御能力。它们还能减轻发炎、促进组织修復并维持屏障完整性。

Cochrane系统综述与总结统合分析发现，益生菌可降低抗生素相关性腹泻 (AAD) 的风险。儿童的总估计值值为相对风险 0.46（95% CI 0.35-0.61），在基准风险为中等的试验中，NNT 约为 10。

消费者对免疫支持和肠道健康的认识不断提高

随着人们日益意识到肠道菌丛对整体健康的重要性，益生菌生物膜保护剂的需求也随之成长。消费者越来越多地寻求自然疗法来增强免疫系统功能、平衡消化系统并预防疾病，尤其是在压力、肥胖和抗生素滥用等生活方式相关的健康问题损害肠道健康的情况下。新冠疫情激发了人们对日常益生菌消费的兴趣，并提高了全球对其免疫恢復能力的认识。此外，益生菌生物膜保护剂由于其在肠道中更强大的定植和存活能力，能够为消费者带来比传统益生菌更持久的益处。

研发成本高

高昂的研发成本是限制益生菌生物膜保护剂市场的主要因素之一。与传统益生菌不同，以生物膜为基础的产品需要菌株工程、封装和微生物组分析等最尖端科技，以确保稳定性、安全性和有效性。进行证明功效和合规性所需的临床前和临床试验成本极为高昂。由于缺乏资金，中小企业往往难以竞争，而大型企业则面临着证明其研发投资已产生效益的压力。

扩大皮肤护肤和皮肤病学的应用

除了肠道健康之外，益生菌生物膜保护剂在皮肤科和化妆品科学领域也拥有巨大的潜力。某些益生菌菌株已被证明能够在皮肤表面形成生物膜，增强皮肤屏障功能，减少病原体定植，并增强皮肤微生物群。这为治疗牛皮癣、痤疮、湿疹和过早老化的局部治疗开闢了新的途径。以生物膜为基础的益生菌还可以透过提供持久的保护作用来提升化妆品乳液、精华液和乳霜的功效。微生物组美容的兴起以及消费者对有科学依据的天然护肤产品的需求，为产品多样化提供了重要的机会。化妆品品牌和生技公司可以合作开发生物膜益生菌，并将护肤转变为微生物组主导的疗法。

价格压力大，市场竞争激烈

益生菌生物膜保护剂市场正面临新兴和成熟益生菌生产商的激烈竞争，这些生产商纷纷提供以微生物组为基础的替代品。由于传统益生菌价格更实惠、更容易取得，基于生物膜的产品在维持高价位方面面临挑战。此外，微生物组调节剂、后生元、合益素和益生元的快速崛起，扩大了消费者的选择，也加剧了竞争。市场占有率很可能被拥有更庞大分销网络和资源的跨国公司所主导，从而限制了小型创新企业的机会。这种竞争环境可能导致价格战，降低利润率，并推迟对新创意的投资，尤其是对于那些寻求推广创新基于生物膜的益生菌产品的新兴企业而言。

COVID-19的影响：

新冠疫情既是催化剂，也是挑战，对益生菌生物膜保护剂市场产生了重大影响。在需求方面，这场危机提高了全球对免疫力、肠道健康和预防性保健的认识，激发了消费者对功效得到证实的益生菌的兴趣。随着健康意识的增强，以生物膜为基础的益生菌因其比传统菌株更优异的保护效果、更长的定植期和更高的存活率而越来越受欢迎。供应链中断、原材料短缺以及封锁期间的物流困难是市场必须克服的一些挑战。儘管面临这些挫折，新冠疫情最终还是透过将益生菌生物膜保护剂确立为膳食补充剂和机能性食品中关键的免疫支持创新，增加了长期需求。

食品和饮料保鲜市场预计将成为预测期内最大的市场

预计食品和饮料保鲜领域将在预测期内占据最大的市场占有率。这种主导地位是由对富含益生菌的膳食补充剂、乳製品替代品、发酵饮料和机能性食品不断增长的需求所驱动的。生物膜衍生的益生菌非常适合加入消费食品中，因为它们具有出色的货架稳定性、耐受恶劣加工条件的能力以及在消化和储存过程中的高存活率。消费者对天然、洁净标示和增强免疫力产品的偏好日益增长，进一步推动了该市场的应用。此外，食品製造商和生物技术公司之间的合作使富含益生菌的产品更加广泛地普及，确保食品和饮料仍然是市场的主要成长引擎。

预计预测期内消费者健康和保健领域将以最高的复合年增长率成长。

预计消费者健康与保健领域将在预测期内实现最高成长率。全球对肠道菌丛平衡、增强免疫力和预防性医疗保健的日益关注，推动了注重健康的消费者对益生菌的需求成长。基于生物膜的益生菌在这个市场中独树一帜，因为它们比传统益生菌具有更高的活力、更长的定植时间和更持久的效果。机能性食品的日益普及，也推动了益生菌的普及。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场占有率，这得益于快速的都市化、日益增强的健康意识以及对发酵食品的文化接受度。益生菌相关的良好饮食习惯以及中等收入人口增长带来的可支配收入的提高，推动了益生菌需求的增长，其中中国、日本、韩国和印度等国家的需求最高。政府支持预防性医疗保健和机能性食品的计画正在进一步加速其普及。不断扩大的研发支出、区域製造以及广泛的零售和电子商务分销网络进一步支持了该地区的市场成长。此外，由于消费者群体多样化以及对免疫力和健康的日益关注，亚太地区仍然是全球益生菌生物膜保护剂消费的领先地区。

复合年增长率最高的地区：

在预测期内，由于微生物组研究的快速发展、消费者对预防性医疗保健的高需求以及膳食补充剂和机能性食品的日益普及，北美预计将实现最高的复合年增长率。该地区高度发达的医疗保健基础设施以及对益生菌创新和基于生物膜的递送系统不断增加的投资，推动了益生菌的快速普及。随着人们对免疫力、肠道健康和个人化营养的认识不断提高，尤其是透过优质补充剂和强化食品，市场渗透率进一步提升。此外，製药、食品和生技公司之间的策略联盟也增加了产品的供应。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球益生菌生物膜保护剂市场（依产品类型）

  • 益生菌菌株
    • 芽孢桿菌菌株
    • 乳酸菌菌株
    • 双歧桿菌菌株
  • 后生元和合合益素
  • 交货方式
    • 胶囊
    • 粉末
    • 机能性食品
    • 外用凝胶/乳膏
    • 液体悬浮液
    • 微胶囊形式

6. 全球益生菌生物膜保护剂市场（依应用）

  • 医疗设备生物膜保护
  • 食品和饮料储存
  • 农产品保护
  • 环境和工业清洁
  • 其他用途
    • 水产养殖
    • 兽医健康
    • 口腔卫生
    • 纤维和表面涂层

7. 全球益生菌生物膜保护剂市场（按最终用户）

  • 医院和诊所
  • 製药公司
  • 消费者健康与保健
  • 研究机构
  • 个人护理和化妆品
  • 兽医诊所和动物医疗公司

8. 全球益生菌生物膜保护剂市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章：主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章：企业概况

  • Chr Hansen Holding AS
  • Kerry Group PLC
  • DuPont de Nemours, Inc.
  • BioGaia AB
  • Nestle SA
  • DSM-Firmenich
  • Lifeway Foods Inc.
  • Yakult Honsha Co., Ltd.
  • Danone SA
  • Lallemand Inc.
  • General Mills Inc.
  • PepsiCo Inc.
  • Nuron Biotech Inc.
  • Walvax Biotechnology Co., Ltd.
  • Morinaga Milk Industry Co. Ltd
  • Sanzyme Biologics Pvt. Ltd.
  • Now Foods
Product Code: SMRC30478

According to Stratistics MRC, the Global Probiotic Biofilm Protectors Market is accounted for $1.73 billion in 2025 and is expected to reach $4.76 billion by 2032 growing at a CAGR of 15.5% during the forecast period. Probiotic biofilm protectors are good bacteria that grow on mucosal surfaces like the skin, mouth, or stomach to create a protective layer called a biofilm. In order to stop dangerous pathogens from adhering, colonizing, and causing infections, this biofilm serves as a biological and physical barrier. In contrast to pathogenic biofilms, which are frequently linked to illness, probiotic biofilms strengthen the body's defenses by boosting immunity, generating antimicrobial compounds, and stabilizing the microbiota. They also lessen inflammation, encourage tissue repair, and preserve the integrity of the barrier.

According to Cochrane systematic reviews and pooled meta-analyses, probiotics reduce the risk of antibiotic-associated diarrhea (AAD); pooled estimates in children show a relative risk ≈0.46 (95% CI ~0.35-0.61) with an approximate NNT ≈10 in trials with moderate baseline risk.

Market Dynamics:

Driver:

Growing consumer knowledge of immune support and gut health

Growing awareness of the importance of the gut microbiota to general health is driving up demand for probiotic biofilm protectors. Consumers are increasingly looking for natural remedies for immune system function, digestive balance, and disease prevention, particularly as lifestyle-related health problems like stress, obesity, and antibiotic overuse impair gut health. Interest in taking probiotics on a daily basis increased as a result of the COVID-19 pandemic, which also raised awareness of immune resilience worldwide. Additionally, probiotic biofilm protectors provide longer-lasting benefits to consumers than traditional probiotics because of their superior capacity to colonize and remain in the gut.

Restraint:

High expenses of research and development

The high cost of research and development is one of the main factors limiting the market for probiotic biofilm protectors. In contrast to traditional probiotics, biofilm-based products require cutting-edge technologies like strain engineering, encapsulation, and microbiome analytics to guarantee stability, safety, and effectiveness. Preclinical and clinical trials, which are required to demonstrate benefits and regulatory compliance, are extremely expensive to conduct. Due to a lack of funding, smaller businesses frequently find it difficult to compete, while larger firms are under pressure to demonstrate that their R&D expenditures have produced profitable results.

Opportunity:

Expanding uses in skincare and dermatology

Probiotic biofilm protectors have enormous potential in dermatology and cosmetic science, in addition to gut health. Certain probiotic strains have been shown to be able to create biofilms on the skin's surface, enhancing barrier function, lowering pathogenic colonization, and fortifying the skin's microbiome. This makes room for topical treatments that address psoriasis, acne, eczema, and early aging. Probiotics based on biofilms can also improve the efficacy of cosmetic lotions, serums, and creams by providing longer-lasting protection. A significant opportunity for product diversification is presented by the emergence of "microbiome beauty" and consumer demand for natural skincare products supported by science. Cosmetic brands and biotech companies could collaborate to develop biofilm probiotics, which could turn skincare into microbiome-driven treatments.

Threat:

High levels of price pressure and market competition

The market for probiotic biofilm protectors is seriously threatened by fierce competition from both new and established probiotic producers who are providing microbiome-based alternatives. Because conventional probiotics are still more affordable and accessible, biofilm-based products find it challenging to defend their premium pricing. Furthermore, the quick ascent of microbiome modulators, postbiotics, synbiotics, and prebiotics broadens consumer choices and intensifies competition. Market share can be dominated by multinational corporations with larger distribution networks and resources, which restricts the opportunities for smaller innovators. Price wars could result from this competitive climate, reducing profit margins and delaying investment in new ideas, especially for startups looking to market innovative biofilm-based probiotic products.

Covid-19 Impact:

The COVID-19 pandemic acted as a catalyst and a challenge, significantly affecting the market for probiotic biofilm protectors. On the demand side, the crisis intensified consumer interest in probiotics with demonstrated efficacy by raising awareness of immunity, gut health, and preventive wellness on a global scale. As health consciousness has increased, biofilm-based probiotics have gained popularity because they provide better protection, longer colonization times, and increased survivability than traditional strains. Supply chain interruptions, shortages of raw materials, and logistical difficulties in distribution during lockdowns were some of the challenges the market had to overcome. COVID-19 ultimately increased long-term demand by establishing probiotic biofilm protectors as important immune-supporting innovations in nutraceuticals and functional foods, despite these setbacks.

The food and beverages preservation segment is expected to be the largest during the forecast period

The food and beverages preservation segment is expected to account for the largest market share during the forecast period. The growing demand for probiotic-fortified nutraceuticals, dairy substitutes, fermented drinks, and functional foods is what is causing this dominance. Probiotics derived from biofilms have excellent shelf stability, resistance to severe processing conditions, and increased survivability during digestion and storage, which makes them perfect for incorporation into consumer foods. Adoption in this market has been further accelerated by rising consumer preference for natural, clean-label and immunity-boosting products. Additionally, probiotic-enriched products are becoming more widely available owing to partnerships between food manufacturers and biotech companies, guaranteeing that food and beverages will continue to be the market's main growth engine.

The consumer health & wellness segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the consumer health & wellness segment is predicted to witness the highest growth rate. Growing awareness of gut microbiome balance, immunity enhancement, and preventive healthcare around the world is driving high demand from consumers who are concerned about their health. In this market, biofilm-based probiotics are unique because they are more survivable, colonize for longer periods of time, and provide longer-lasting benefits than traditional probiotics. The growing accessibility of functional foods, probiotic-enriched supplements, and beverages designed for everyday well-being is propelling widespread adoption.

Region with largest share:

During the forecast period, the Asia-Pacific region is expected to hold the largest market share, driven by its rapid urbanization, rising health consciousness, and ingrained cultural acceptance of fermented foods. Strong probiotic-related dietary traditions and growing disposable incomes among growing middle-class populations support demand, which is highest in countries like China, Japan, South Korea, and India. Adoption is further accelerated by government programs supporting preventive healthcare and functional foods. The region's market growth is further supported by expanding R&D expenditures, regional manufacturing, and extensive retail and e-commerce distribution networks. Furthermore, Asia-Pacific continues to be the world's leading region for the consumption of probiotic biofilm protectors due to its wide range of consumers and growing emphasis on immunity and wellness.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the quick development of microbiome research, the high demand from consumers for preventive healthcare, and the growing acceptance of nutraceuticals and functional foods. Accelerated adoption is supported by the region's highly developed healthcare infrastructure, growing investments in probiotic innovation, and biofilm-based delivery systems. Market penetration is further increased by rising awareness of immunity, gut health, and customized nutrition, particularly through high-end supplements and fortified foods. Moreover, the availability of products is also being increased by strategic alliances between pharmaceutical, food, and biotech companies.

Key players in the market

Some of the key players in Probiotic Biofilm Protectors Market include Chr Hansen Holding AS, Kerry Group PLC, DuPont de Nemours, Inc., BioGaia AB, Nestle S.A., DSM-Firmenich, Lifeway Foods Inc., Yakult Honsha Co., Ltd., Danone SA, Lallemand Inc., General Mills Inc., PepsiCo Inc., Nuron Biotech Inc., Walvax Biotechnology Co., Ltd., Morinaga Milk Industry Co. Ltd, Sanzyme Biologics Pvt. Ltd. and Now Foods.

Key Developments:

In May 2025, Nestle SA, the parent company of Nestle India, has made a financial investment in India-based pet food company, Drools Pet Food Private Limited, marking its first such investment in the country. Under this agreement, Nestle S.A will pick up a minority stake in Drools for an undisclosed amount. This comes at a time when Drool is positioning itself as a global pet food brand with Indian roots.

In November 2024, Kerry Group plc announced that it has entered into an agreement with Kerry Co-Operative Creameries Limited to sell Kerry Dairy Holdings Limited to the Co-Op for a total expected consideration of €500 million. Kerry Dairy Ireland consists of Dairy Consumer Products, with its leading range of well-loved brands across cheese, cheese snacks, dairy snacks, and dairy spreads, which can be found in chilled cabinets across retailers in the UK and Ireland.

In October 2024, DuPont and Zhen Ding Technology Group announced they have entered into a strategic cooperation agreement in advanced printed circuit board (PCBs) technology. Through this strategic partnership, DuPont and Zhen Ding will work to enhance end-user applications, advance cutting-edge research and development, improve material performance, and promote the sustainable development of the electronics sector.

Product Types Covered:

  • Probiotic Strains
  • Postbiotics & Synbiotics
  • Delivery Formats

Applications Covered:

  • Medical devices Biofilm Protection
  • Food and Beverages Preservation
  • Agricultural Products Protection
  • Environmental and Industrial Cleaning
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Consumer Health & Wellness
  • Research Institutions
  • Personal Care and Cosmetics
  • Veterinary Clinics & Animal Health Companies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Probiotic Biofilm Protectors Market, By Product Type

  • 5.1 Introduction
  • 5.2 Probiotic Strains
    • 5.2.1 Bacillus Strains
    • 5.2.2 Lactobacillus Strains
    • 5.2.3 Bifidobacterium Strains
  • 5.3 Postbiotics & Synbiotics
  • 5.4 Delivery Formats
    • 5.4.1 Capsules
    • 5.4.2 Powders
    • 5.4.3 Functional Foods
    • 5.4.4 Topical Gels/Creams
    • 5.4.5 Liquid Suspensions
    • 5.4.6 Microencapsulated Forms

6 Global Probiotic Biofilm Protectors Market, By Application

  • 6.1 Introduction
  • 6.2 Medical devices Biofilm Protection
  • 6.3 Food and Beverages Preservation
  • 6.4 Agricultural Products Protection
  • 6.5 Environmental and Industrial Cleaning
  • 6.6 Other Applications
    • 6.6.1 Aquaculture
    • 6.6.2 Veterinary Health
    • 6.6.3 Oral Hygiene
    • 6.6.4 Textile & Surface Coatings

7 Global Probiotic Biofilm Protectors Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals & Clinics
  • 7.3 Pharmaceutical Companies
  • 7.4 Consumer Health & Wellness
  • 7.5 Research Institutions
  • 7.6 Personal Care and Cosmetics
  • 7.7 Veterinary Clinics & Animal Health Companies

8 Global Probiotic Biofilm Protectors Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Chr Hansen Holding AS
  • 10.2 Kerry Group PLC
  • 10.3 DuPont de Nemours, Inc.
  • 10.4 BioGaia AB
  • 10.5 Nestle S.A.
  • 10.6 DSM-Firmenich
  • 10.7 Lifeway Foods Inc.
  • 10.8 Yakult Honsha Co., Ltd.
  • 10.9 Danone SA
  • 10.10 Lallemand Inc.
  • 10.11 General Mills Inc.
  • 10.12 PepsiCo Inc.
  • 10.13 Nuron Biotech Inc.
  • 10.14 Walvax Biotechnology Co., Ltd.
  • 10.15 Morinaga Milk Industry Co. Ltd
  • 10.16 Sanzyme Biologics Pvt. Ltd.
  • 10.17 Now Foods

List of Tables

  • Table 1 Global Probiotic Biofilm Protectors Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Probiotic Biofilm Protectors Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Probiotic Biofilm Protectors Market Outlook, By Probiotic Strains (2024-2032) ($MN)
  • Table 4 Global Probiotic Biofilm Protectors Market Outlook, By Bacillus Strains (2024-2032) ($MN)
  • Table 5 Global Probiotic Biofilm Protectors Market Outlook, By Lactobacillus Strains (2024-2032) ($MN)
  • Table 6 Global Probiotic Biofilm Protectors Market Outlook, By Bifidobacterium Strains (2024-2032) ($MN)
  • Table 7 Global Probiotic Biofilm Protectors Market Outlook, By Postbiotics & Synbiotics (2024-2032) ($MN)
  • Table 8 Global Probiotic Biofilm Protectors Market Outlook, By Delivery Formats (2024-2032) ($MN)
  • Table 9 Global Probiotic Biofilm Protectors Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 10 Global Probiotic Biofilm Protectors Market Outlook, By Powders (2024-2032) ($MN)
  • Table 11 Global Probiotic Biofilm Protectors Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 12 Global Probiotic Biofilm Protectors Market Outlook, By Topical Gels/Creams (2024-2032) ($MN)
  • Table 13 Global Probiotic Biofilm Protectors Market Outlook, By Liquid Suspensions (2024-2032) ($MN)
  • Table 14 Global Probiotic Biofilm Protectors Market Outlook, By Microencapsulated Forms (2024-2032) ($MN)
  • Table 15 Global Probiotic Biofilm Protectors Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Probiotic Biofilm Protectors Market Outlook, By Medical devices Biofilm Protection (2024-2032) ($MN)
  • Table 17 Global Probiotic Biofilm Protectors Market Outlook, By Food and Beverages Preservation (2024-2032) ($MN)
  • Table 18 Global Probiotic Biofilm Protectors Market Outlook, By Agricultural Products Protection (2024-2032) ($MN)
  • Table 19 Global Probiotic Biofilm Protectors Market Outlook, By Environmental and Industrial Cleaning (2024-2032) ($MN)
  • Table 20 Global Probiotic Biofilm Protectors Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Probiotic Biofilm Protectors Market Outlook, By Aquaculture (2024-2032) ($MN)
  • Table 22 Global Probiotic Biofilm Protectors Market Outlook, By Veterinary Health (2024-2032) ($MN)
  • Table 23 Global Probiotic Biofilm Protectors Market Outlook, By Oral Hygiene (2024-2032) ($MN)
  • Table 24 Global Probiotic Biofilm Protectors Market Outlook, By Textile & Surface Coatings (2024-2032) ($MN)
  • Table 25 Global Probiotic Biofilm Protectors Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global Probiotic Biofilm Protectors Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 27 Global Probiotic Biofilm Protectors Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
  • Table 28 Global Probiotic Biofilm Protectors Market Outlook, By Consumer Health & Wellness (2024-2032) ($MN)
  • Table 29 Global Probiotic Biofilm Protectors Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 30 Global Probiotic Biofilm Protectors Market Outlook, By Personal Care and Cosmetics (2024-2032) ($MN)
  • Table 31 Global Probiotic Biofilm Protectors Market Outlook, By Veterinary Clinics & Animal Health Companies (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.